Form 8-K - Current report:
SEC Accession No. 0001193125-25-084319
Filing Date
2025-04-17
Accepted
2025-04-17 16:08:14
Documents
13
Period of Report
2025-04-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d861784d8k.htm   iXBRL 8-K 23452
  Complete submission text file 0001193125-25-084319.txt   145096

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bdsx-20250415.xsd EX-101.SCH 2841
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsx-20250415_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsx-20250415_pre.xml EX-101.PRE 11252
16 EXTRACTED XBRL INSTANCE DOCUMENT d861784d8k_htm.xml XML 3661
Mailing Address 919 WEST DILLON ROAD LOUISVILLE CO 80027
Business Address 919 WEST DILLON ROAD LOUISVILLE CO 80027 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39659 | Film No.: 25847352
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)